Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.

Kennedy NJ, Spithill TW, Tennent J, Wood PR, Piedrafita D.

Vaccine. 2006 Feb 13;24(7):970-9. Epub 2005 Sep 6.

PMID:
16242220
2.

The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.

Drew DR, Boyle JS, Lew AM, Lightowlers MW, Chaplin PJ, Strugnell RA.

Vaccine. 2001 Aug 14;19(31):4417-28.

PMID:
11483267
3.
4.

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.

Kojima Y, Xin KQ, Ooki T, Hamajima K, Oikawa T, Shinoda K, Ozaki T, Hoshino Y, Jounai N, Nakazawa M, Klinman D, Okuda K.

Vaccine. 2002 Jul 26;20(23-24):2857-65.

PMID:
12126895
5.

The role of CpG dinucleotides in DNA vaccines.

Krieg AM, Yi AK, Schorr J, Davis HL.

Trends Microbiol. 1998 Jan;6(1):23-7. Review.

PMID:
9481820
6.

The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy.

Scheerlinck JP, Casey G, McWaters P, Kelly J, Woollard D, Lightowlers MW, Tennent JM, Chaplin PJ.

Vaccine. 2001 Jul 16;19(28-29):4053-60.

PMID:
11427282
7.

Fusion protein encoded by a CTLA-4 targeted DNA construct binds to human dendritic cells.

Xu QA, Zhang F, Fan MW, Liu ST, Li YH, Yu F, Tian QW.

Immunol Invest. 2009;38(2):123-31. doi: 10.1080/08820130802664363. Erratum in: Immunol Invest. 2009;38(5):447.

PMID:
19330622
8.
9.

Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations.

HiszczyƄska-Sawicka E, Li H, Xu JB, Oledzka G, Kur J, Bickerstaffe R, Stankiewicz M.

Exp Parasitol. 2010 Apr;124(4):365-72. doi: 10.1016/j.exppara.2009.11.015. Epub 2009 Dec 3.

PMID:
19962376
10.
11.

Enhanced efficacy of CTLA-4 fusion anti-caries DNA vaccines in gnotobiotic hamsters.

Zhang F, Li YH, Fan MW, Jia R, Xu QA, Guo JH, Yu F, Tian QW.

Acta Pharmacol Sin. 2007 Aug;28(8):1236-42.

13.
14.

CpG motifs for optimization of DNA vaccines.

Davis HL.

Dev Biol (Basel). 2000;104:165-9. Review.

PMID:
11713816
15.

Non-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in mice.

Yoshikawa T, Imazu S, Gao JQ, Hayashi K, Tsuda Y, Okada N, Tsutsumi Y, Akashi M, Mayumi T, Nakagawa S.

Biol Pharm Bull. 2006 Jan;29(1):105-9.

16.
18.

TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

Babiuk S, Mookherjee N, Pontarollo R, Griebel P, van Drunen Littel-van den Hurk S, Hecker R, Babiuk L.

Immunology. 2004 Sep;113(1):114-20.

19.

Adjuvant formulations and delivery systems for DNA vaccines.

Sasaki S, Takeshita F, Xin KQ, Ishii N, Okuda K.

Methods. 2003 Nov;31(3):243-54. Review.

PMID:
14511957

Supplemental Content

Support Center